Vas Narasimhan en LinkedIn: Returning to my alma mater is always a source of energy and optimism, as… | 33 comentarios
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
![Novartis CEO touts 25 potential—and diverse—blockbuster launches. But is its portfolio too scattered? | Fierce Pharma Novartis CEO touts 25 potential—and diverse—blockbuster launches. But is its portfolio too scattered? | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1558705140/Novartis%20CEO%20Vas%20Narasimhan%202019.jpg/Novartis%20CEO%20Vas%20Narasimhan%202019.jpg?VersionId=blZa09pz4N.eb1.gXziPhUZ7LRAPTMfk)
Novartis CEO touts 25 potential—and diverse—blockbuster launches. But is its portfolio too scattered? | Fierce Pharma
![Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises - YouTube Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises - YouTube](https://i.ytimg.com/vi/hPieHBYPC7Y/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLCMYMkEsIthW3EhkGvLn47usCdF3w)